Comparative Study Of Parpatadhyarista And Dugdhikadi Yog in Ashtheela

A Comparative Study Of Parpatadhyarista And Dugdhikadi Yog In The Management Of Ashtheela w.s.r. To Benign Prostate Hyperplasia

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028500

Enrollment

Registered

2020-10-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N400- Benign prostatic hyperplasia without lower urinary tract symptoms

Interventions

Intervention1: Oral administration of parpatadhyarista: Drug- Parpatadhyarista Route of administration- oral Dose- 20 ml twice daily with equal quantity of water Duration- 60 days Control Interventio

Eligibility

Inclusion criteria

Inclusion criteria: Pre diagnose case of bph, post voidal residual volume upto 100ml,usg suggestive of bph, frquency of urine is >2 times and < 5 times in night

Exclusion criteria

Exclusion criteria: Patients with evidence of malignancy, with evidence of heart failure, carcinoma of prostate, patients with poorly controlled diabetes mellitus and hypertention, severe urinary tract infections

Design outcomes

Primary

Measure	Time frame
Improvement in subjective and objective criteriaTimepoint: 60 days	—

Secondary

Measure	Time frame
Improvement in subjective criteria with no associated complaintsTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Tarun Meena

University College of Ayurveda, Jodhpur

guptadrrajeshkumargupta@gmail.com9636520573

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026